PGIM India Healthcare Fund
Holdings
33
Concentrated
Top 10 weight
63%
Concentration
Active share
90%
Highly Differentiated
Equity
98%
Asset allocation
Portfolio
7Sectors
6Large positions
65.2%Top: Pharmaceuticals & Biotechnology
2.1%Cash
Market-cap allocation
Large cap33%
Mid cap18%
Small cap46%
Asset allocation
Equity98%
Cash2%
Top holdings
11.3%
Divi's Laboratories Ltd.EQUITY
10.0%6.5%
Aster DM Healthcare Ltd.EQUITY
6.4%Rubicon Research Ltd.EQUITY
6.0%Mankind Pharma Ltd.EQUITY
5.2%5.0%
Ajanta Pharma Ltd.EQUITY
4.7%4.2%
Dr. Lal Path Labs Ltd.EQUITY
3.3%3.2%
3.1%
Abbott India Ltd.EQUITY
2.9%2.7%
2.7%
Sai Life Sciences LtdEQUITY
2.6%Anthem Biosciences Ltd.EQUITY
2.2%2.1%
Global Health Ltd.EQUITY
1.8%Cipla Ltd.EQUITY
1.6%Fortis Healthcare Ltd.EQUITY
1.5%PB Fintech Ltd.EQUITY
1.4%Lupin Ltd.EQUITY
1.4%Pfizer Ltd.EQUITY
1.3%1.2%
1.1%
Orchid Pharma Ltd.EQUITY
0.85%Lenskart Solutions Ltd.EQUITY
0.74%0.70%
Sagility Ltd.EQUITY
0.53%0.52%
0.20%
AI Smart summary
Portfolio read
- 98% equity, 2% cash.
- 33 disclosed positions across 7 classified equity sectors.
- Largest equity sector is Pharmaceuticals & Biotechnology at 65.2% of the portfolio.
Watchpoints
- Top 10 positions account for 63%, indicating high portfolio concentration.
- Small-cap exposure is 46%, which may increase volatility and liquidity risk.
- Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 65%.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in Sectoral / Thematic.
JioBlackRock Sector Rotation Fund291 holdings · 33% top 10 · 36% AS
Bandhan Business Cycle Fund95 holdings · 35% top 10 · 65% AS
WhiteOak Capital Special Opportunities Fund91 holdings · 29% top 10 · 73% AS
UTI Quant Fund90 holdings · 35% top 10 · 66% AS
ICICI Prudential Manufacturing Fund86 holdings · 37% top 10 · 79% AS
Axis India Manufacturing Fund86 holdings · 34% top 10 · 73% AS
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
65.2%
25.8%
3.1%
1.4%
1.2%
0.7%
0.5%